Alunbrig® (brigatinib)
for Lung Cancer

Alunbrig (brigatinib) is an antineoplastic medicine used to treat metastatic non-small cell lung cancer (NSCLC) in patients with an abnormal ALK gene. Alunbrig works by slowing or stopping the growth of cancer cells, helping the body to destroy them.

Heart